CME/CE
Episodes 1-16 of 118
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
- CME/CE
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
0.25 creditsVallerie V. McLaughlin, MD
Mazen Hanna, MD
Vallerie V. McLaughlin, MD
Thomas Cascino, MD
Bradley A. Maron, MD
Vallerie V. McLaughlin, MD
Victor Moles, MD
Ioana Preston, MD
- CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
1.00 creditRobert P. Frantz, MD, FACC
Vallerie V. McLaughlin, MD
Sonja Bartolomei, MD
- CME/CE
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
0.50 creditsPablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Csaba P. Kovesdy, MD
Finnian R. Mc Causland, MD
Csaba P. Kovesdy, MD
Finnian R. Mc Causland, MD
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne
Akshay S. Desai, MD
John McMurray, MD
Akshay S. Desai, MD
John McMurray, MD
Ulrich Laufs, MD, PhD
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesKausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program creditsProf. Kausik Ray
Pasquale Perrone-Filardi, MD, PhD
- Prev
- Next